Bumetanide is a potent loop diuretic used to treat fluid overload (edema) caused by heart failure, liver disease, or kidney disease.
Reviewed by:
Dr. Steve Malen, PharmD
Dr. Steven Blikstein, PharmD
Strength
How would you like to get this medication?
Choose a strength and quantity to continue.
Bumetanide (Bumex) is a loop diuretic that inhibits sodium, potassium, and chloride reabsorption in the loop of Henle, promoting rapid diuresis. It is used to treat edema associated with heart failure, cirrhosis of the liver, and kidney disease, including nephrotic syndrome. Bumetanide is significantly more potent per milligram than furosemide; typical oral doses range from 0.5 mg to 2 mg once or twice daily, with a maximum of 10 mg per day. It is also available as an intravenous injection for patients unable to take oral medication or requiring rapid effect. Common side effects include electrolyte imbalances (low potassium, sodium, or magnesium), dehydration, dizziness, and low blood pressure. High doses, particularly given intravenously, carry a risk of hearing loss or tinnitus (ototoxicity), especially with concurrent use of other ototoxic drugs. Regular monitoring of electrolytes, kidney function, and blood pressure is recommended during treatment.
Complete a health screening
A short questionnaire about your health history and current symptoms — takes about 2 minutes.
Provider reviews your answers
Provider review within 24 hours.
Prescription fulfilled
If approved, your Rx is sent to Invictus Pharmacy and you're notified by text or email. Free nationwide shipping.
Bumetanide is a potent loop diuretic used to treat fluid overload (edema) from heart failure, liver disease, or kidney disease. It works by blocking sodium, potassium, and chloride reabsorption in the kidney, promoting rapid fluid loss. It is considerably more potent per milligram than furosemide.
Common side effects include electrolyte imbalances (low potassium, sodium, or magnesium), dehydration, dizziness, and low blood pressure.
Important: High doses, particularly given intravenously, carry a risk of hearing loss or ringing in the ears (ototoxicity), especially when combined with other ototoxic medications.
Regular monitoring of electrolytes, kidney function, and blood pressure is recommended during treatment.